AIMS: Activation of specific signaling pathways in response to mechanical trauma causes delayed neuronal apoptosis; GSK-3β/β-catenin signaling plays a critical role in the apoptosis of neurons in CNS diseases, SGK was discovered as a regulator of GSK-3β/β-catenin pathway, The goal of this study was to determine if the mechanism of cell death or survival mediated by the SGK/GSK-3β/β-catenin pathway is involved in a rat model of TBI. MAIN METHODS: Here, an acute traumatic brain injury model was applied to investigate the expression change and possible roles of SGK, Expression of SGK, and total-GSK-3β, phospho-GSK3β on ser-9, beta-catenin, and caspase-3 were examined by immunohistochemistry and Western blot analysis. Double immunofluorescent staining was used to observe the SGK localizations. Si-RNA was performed to identify whether SGK regulates neuron apoptosis via GSK-3β/β-catenin pathway, ultimately inhibit caspase-3 activation. KEY FINDINGS: Temporally, SGK expression showed an increase pattern after TBI and reached a peak at day 3. Spatially, SGK was widely expressed in the neuron, rarely in astrocytes and oligodendrocytes; in addition, the expression patterns of active caspase-3 and phospho-GSK3β were parallel with that of SGK, at the same time, the expression of β-catenin shows similarity with SGK. In vitro, to further investigate the function of SGK, a neuronal cell line PC12 was employed to establish an apoptosis model. We analyzed the association of SGK with apoptosis on PC12 cells by western blot, immunofluorescent labeling and siRNA. SIGNIFICANCE: the results implied that SGK plays an important role in neuron apoptosis via the regulation of GSK3β/β-catenin signaling pathway; ultimately inhibit caspase-3 activation. Taken together, we inferred traumatic brain injury induced an upregulation of SGK in the central nervous system, which show a protective role in neuron apoptosis.
AIMS: Activation of specific signaling pathways in response to mechanical trauma causes delayed neuronal apoptosis; GSK-3β/β-catenin signaling plays a critical role in the apoptosis of neurons in CNS diseases, SGK was discovered as a regulator of GSK-3β/β-catenin pathway, The goal of this study was to determine if the mechanism of cell death or survival mediated by the SGK/GSK-3β/β-catenin pathway is involved in a rat model of TBI. MAIN METHODS: Here, an acute traumatic brain injury model was applied to investigate the expression change and possible roles of SGK, Expression of SGK, and total-GSK-3β, phospho-GSK3β on ser-9, beta-catenin, and caspase-3 were examined by immunohistochemistry and Western blot analysis. Double immunofluorescent staining was used to observe the SGK localizations. Si-RNA was performed to identify whether SGK regulates neuron apoptosis via GSK-3β/β-catenin pathway, ultimately inhibit caspase-3 activation. KEY FINDINGS: Temporally, SGK expression showed an increase pattern after TBI and reached a peak at day 3. Spatially, SGK was widely expressed in the neuron, rarely in astrocytes and oligodendrocytes; in addition, the expression patterns of active caspase-3 and phospho-GSK3β were parallel with that of SGK, at the same time, the expression of β-catenin shows similarity with SGK. In vitro, to further investigate the function of SGK, a neuronal cell line PC12 was employed to establish an apoptosis model. We analyzed the association of SGK with apoptosis on PC12 cells by western blot, immunofluorescent labeling and siRNA. SIGNIFICANCE: the results implied that SGK plays an important role in neuron apoptosis via the regulation of GSK3β/β-catenin signaling pathway; ultimately inhibit caspase-3 activation. Taken together, we inferred traumatic brain injury induced an upregulation of SGK in the central nervous system, which show a protective role in neuron apoptosis.
Authors: Teuntje M J C Andriessen; Janneke Horn; Gaby Franschman; Joukje van der Naalt; Iain Haitsma; Bram Jacobs; Ewout W Steyerberg; Pieter E Vos Journal: J Neurotrauma Date: 2011-09-27 Impact factor: 5.269
Authors: Jed A Hartings; M Ross Bullock; David O Okonkwo; Lilian S Murray; Gordon D Murray; Martin Fabricius; Andrew Ir Maas; Johannes Woitzik; Oliver Sakowitz; Bruce Mathern; Bob Roozenbeek; Hester Lingsma; Jens P Dreier; Ava M Puccio; Lori A Shutter; Clemens Pahl; Anthony J Strong Journal: Lancet Neurol Date: 2011-11-03 Impact factor: 44.182
Authors: H Dudek; S R Datta; T F Franke; M J Birnbaum; R Yao; G M Cooper; R A Segal; D R Kaplan; M E Greenberg Journal: Science Date: 1997-01-31 Impact factor: 47.728
Authors: Arjang Salehi; Amandine Jullienne; Mohsen Baghchechi; Mary Hamer; Mark Walsworth; Virginia Donovan; Jiping Tang; John H Zhang; William J Pearce; Andre Obenaus Journal: J Cereb Blood Flow Metab Date: 2017-11-21 Impact factor: 6.200
Authors: D Pastore; D Della-Morte; A Coppola; B Capuani; M F Lombardo; F Pacifici; F Ferrelli; R Arriga; C Mammi; M Federici; A Bellia; N Di Daniele; M Tesauro; G Donadel; D Noto; P Sbraccia; G Sconocchia; D Lauro Journal: Cell Death Dis Date: 2015-09-17 Impact factor: 8.469
Authors: Erika A Correll; Benjamin J Ramser; Maxon V Knott; Robert E McCullumsmith; Jennifer L McGuire; Laura B Ngwenya Journal: IBRO Neurosci Rep Date: 2021-02-03